Immediate clinical and haemodynamic benefits of restoration of pulmonary valvar competence in patients with pulmonary hypertension

Objective: To analyse the potential benefit of restoration of pulmonary valvar competence in patients with severe pulmonary regurgitation (PR) and pulmonary hypertension (PH) associated with congenital heart disease. Design: Retrospective study. Setting: Tertiary paediatric and adult congenital heart cardiac centre. Interventions: Percutaneous pulmonary valve implantation (PPVI). Patients: All patients who underwent PPVI for treatment of PR in the presence of PH (mean PAP >25 mm Hg). Results: Seven patients with severe PH as a result of congenital heart disease and severe PR underwent PPVI. The valve implantation procedure was feasible and uncomplicated in all seven cases, successfully abolishing PR. There was a significant increase in diastolic (15.4 (7.3) to 34.0 (8.5) mm Hg; p = 0.007) and mean (29.7 (8.1) to 41.3 (12.9) mm Hg; p = 0.034) pulmonary artery pressures, and an improvement in NYHA functional class (from median IV to median III; p<0.008). Peripheral oxygen saturations rose from 85.9% (11.0%) to 91.7% (8.3%) (p = 0.036). Right ventricular (RV) volumes decreased (from 157.0 (44.7) to 140.3 (53.3) ml/m2), while effective RV stroke volume increased (from 23.4 (9.3) to 41.0 (11.6) ml/m2). During a median follow-up of 20.3 months (range 1.3–47.5), valvar competence was well maintained despite near systemic pulmonary pressures. None of the valved stents were explanted during follow-up. Conclusion: Trans-catheter treatment of PR in patients with PH is well tolerated and leads to clinical and haemodynamic improvement, most probably caused by a combination of increased pulmonary perfusion pressures and RV efficiency.

[1]  R. R. Wolfe,et al.  Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. , 1993, Circulation.

[2]  E H Bergofsky,et al.  Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.

[3]  W. Weidman.  Second natural history study of congenital heart defects. , 1993, Circulation.

[4]  Vivek Muthurangu,et al.  Percutaneous Pulmonary Valve Implantation: Impact of Evolving Technology and Learning Curve on Clinical Outcome , 2008, Circulation.

[5]  David Bruce Lewis,et al.  Factors Affecting Longevity of Homograft Valves Used in Right Ventricular Outflow Tract Reconstruction for Congenital Heart Disease , 2000, Circulation.

[6]  R. Razavi,et al.  Percutaneous Pulmonary Valve Implantation in Humans: Results in 59 Consecutive Patients , 2005, Circulation.

[7]  R. Friesen,et al.  Perioperative Complications in Children with Pulmonary Hypertension Undergoing Noncardiac Surgery or Cardiac Catheterization , 2007, Anesthesia and analgesia.

[8]  S. Qureshi,et al.  Relief of right ventricular outflow tract obstruction , 2007 .

[9]  B. Reichart,et al.  Right ventricular outflow tract reconstruction with the Contegra bovine jugular vein conduit: a word of caution. , 2004, The Annals of thoracic surgery.

[10]  A. McEwan,et al.  Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. , 2007, British journal of anaesthesia.

[11]  P. Bonhoeffer,et al.  Percutaneous implantation of pulmonary valves for treatment of right ventricular outflow tract dysfunction , 2008, Cardiology in the Young.

[12]  P. Yock,et al.  Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. , 1984, Circulation.

[13]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[14]  M. Elliott,et al.  Fate of subpulmonary homograft conduits: determinants of late homograft failure. , 1998, The Journal of thoracic and cardiovascular surgery.

[15]  S. Dymarkowski,et al.  Clinical cardiac MRI , 2005 .

[16]  A. Taylor,et al.  Physiological consequences of percutaneous pulmonary valve implantation: the different behaviour of volume- and pressure-overloaded ventricles. , 2007, European heart journal.

[17]  A. Taylor,et al.  Risk Stratification, Systematic Classification, and Anticipatory Management Strategies for Stent Fracture After Percutaneous Pulmonary Valve Implantation , 2007, Circulation.

[18]  A. Taylor,et al.  Physiological and Clinical Consequences of Relief of Right Ventricular Outflow Tract Obstruction Late After Repair of Congenital Heart Defects , 2006, Circulation.

[19]  Silvia Schievano,et al.  Variations in right ventricular outflow tract morphology following repair of congenital heart disease: implications for percutaneous pulmonary valve implantation. , 2007, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[20]  D. G. Ritter,et al.  Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction. , 1987, Circulation.

[21]  L. Rubin,et al.  Primary pulmonary hypertension. , 1997, The New England journal of medicine.

[22]  M. Schluchter,et al.  The relation between quantitative right ventricular ejection fraction and indices of tricuspid annular motion and myocardial performance. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.